The half-life of 131 I-insulin in different groups of patients compared with normal subjects.
作者信息
van Rooyen R J, de Bruin E J, Bieler E U, Hoog J M
出版信息
S Afr Med J. 1972 Dec 9;46(49):1927-31.
PMID:4631796
Abstract
摘要
相似文献
1
The half-life of 131 I-insulin in different groups of patients compared with normal subjects.与正常受试者相比，不同组患者中¹³¹I-胰岛素的半衰期。
S Afr Med J. 1972 Dec 9;46(49):1927-31.
2
3
Insulin binding and free insulin in serum of insulin-treated diabetics.
Horm Metab Res. 1973 Mar;5(2):67-70. doi: 10.1055/s-0028-1093984.
4
[Study of insulin-I-131 metabolism in the blood of diabetic patients].[糖尿病患者血液中胰岛素-I-131代谢的研究]
Nihon Naibunpi Gakkai Zasshi. 1965 Nov 20;41(8):969-82. doi: 10.1507/endocrine1927.41.8_969.
5
More from PHARMAC on long-acting insulin analogues: insulin glargine now funded.更多来自药物治疗咨询委员会关于长效胰岛素类似物的信息：甘精胰岛素现已纳入医保。
N Z Med J. 2006 Jun 23;119(1236):U2040.
6
Insulin treatment does not induce glucagon antibodies.胰岛素治疗不会诱导胰高血糖素抗体的产生。
Horm Metab Res. 1971 Jan;3(1):57-8. doi: 10.1055/s-0028-1096760.
7
New Insulins, Biosimilars, and Insulin Therapy.新型胰岛素、生物类似药与胰岛素治疗
Diabetes Technol Ther. 2016 Feb;18 Suppl 1:S43-55. doi: 10.1089/dia.2016.2505.
8
[Immunoreactive insulin in the blood of patients with diabetes treated with insulin and diabetol].接受胰岛素和甲糖宁治疗的糖尿病患者血液中的免疫反应性胰岛素
Wiad Lek. 1980 Nov 15;33(22):1803-8.
9
Insulin therapy-realising the potential.胰岛素治疗——发挥潜能
Int J Obes Relat Metab Disord. 2004 Sep;28 Suppl 2:S1-2. doi: 10.1038/sj.ijo.0802742.
10
[Glucose regulation in the elderly].[老年人的血糖调节]
Sem Hop. 1972 Jun 20;48(29):2095-104.
Zotero 插件